Texas Chapter Recognizes Pharmaceutical Distribution Center, Specialty Pharmacy and Research Network
HOUSTON, March 30 /PRNewswire/ -- Three US Oncology, Inc. businesses have received a Safety Excellence Perfect Record Award in the Occupational Safety & Health category from the Texas chapter of the National Safety Council: US Oncology Research, OncologyRx Care Advantage(TM), and US Oncology Specialty, LP. This is the third time US Oncology companies have received the Occupational Excellence Award from the national organization’s Texas chapter. More information can be found at www.usoncology.com.
The award is presented to companies, units and/or facilities that have completed a period of at least 12 consecutive months without incurring an occupational injury or illness that resulted in days away from work or death.
From 2007 to 2008, US Oncology Specialty, OncologyRx Care Advantage, and US Oncology Research each achieved a zero percent incidence rate for number of days away from work. Following are the 2008 statistics for each:
Formed in 1999, US Oncology collaborates with providers, payers, biotechnology, pharmaceutical and medical equipment manufacturers to increase patient access to advanced cancer care. US Oncology supports one of the nation’s foremost cancer treatment and research networks, accelerating the availability and use of evidence-based medicine and shared best practices.
US Oncology Specialty, LP, is US Oncology’s VAWD(TM) certified drug distribution center focused on delivering safe and effective oncology drugs to community-based practices. Its ePedigree technology tracks all products from manufacturer to the practice, and back again in case of returns.
OncologyRx Care Advantage, a national oral oncology specialty pharmacy, provides patients with convenient home delivery of oral cancer therapies and the additional support necessary for safe and supervised use of these oral therapy treatments. Last year the specialty pharmacy successfully expanded to a national service offering, bringing access to home delivery of oral drugs and critical patient support to cancer patients in all 50 U.S. states and the territory of Puerto Rico.
The US Oncology Research network is an established community-based research operation specializing in comprehensive Phase I-IV trials and translational Phase I research. Supported by US Oncology, the network has played a pivotal role in 35 cancer therapies approved by the Food and Drug Administration and more than 38,500 patients have participated in clinical trials.
About US Oncology
US Oncology, headquartered in the Houston area, works closely with physicians, payers, biotechnology, pharmaceutical and medical equipment manufacturers to identify and deliver innovative services that enhance patient access to advanced cancer care.
US Oncology uses its expertise to support every aspect of the cancer care delivery system--from drug development to distribution and outcomes measurement--enabling the company to help increase the efficiency and safety of cancer care. According to the company’s last quarterly earnings report, US Oncology is affiliated with 1,211 physicians operating in 456 locations, including 94 radiation oncology facilities in 39 states. For more information, visit the company’s Web site, www.usoncology.com.
About the National Safety Council
The National Safety Council is a nonprofit, nongovernmental, international public service organization dedicated to protecting life and promoting health. Members of NSC include more than 45,000 businesses, labor organizations, schools, public agencies, private groups and individuals. Founded in 1913, and chartered by the U.S. Congress in 1953, the primary focus of the NSC is preventing injuries in workplaces, in transportation and in homes and communities.
CONTACT: Jennifer Horspool of US Oncology, +1-281-863-6739,
Jennifer.Horspool@usoncology.com
Web site: http://www.usoncology.com/
